Drug delivery platform technology
Cingulate uses this platform to build and advance a pipeline of pharmaceutical products.
Source: LinkedIn company description · Retrieved October 13, 2026
Cingulate is a biopharmaceutical company advancing a pipeline of pharmaceutical products using its Precision Timed Release drug delivery platform.
The company initially focuses on treatments for ADHD and identifies anxiety disorders as a potential additional therapeutic area for its technology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Cingulate uses this platform to build and advance a pipeline of pharmaceutical products.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 21, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.